Zhou, F., Ren, S., Che, G., Zhou, C., Zhao, X., Zhao, J., Zhao, Y., Duan, J., Wu, L., Zhang, Y., Zhou, C., Zhou, C. (2025). Vebreltinib plus PLB1004 in EGFR-mutated NSCLC with acquired MET amplification or overexpression after failure on EGFR-TKI treatment: A phase Ib/II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8632